The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients

被引：0
|
作者：
Anne Flint
Christoph Kapitza
Charlotte Hindsberger
Milan Zdravkovic
机构：
[1] Novo Nordisk A/S,
[2] Novo Nordisk A/S,undefined
[3] PROFIL Institut für Stoffwechselforschung GmbH,undefined
来源：
Advances in Therapy | 2011年 / 28卷
关键词：
exenatide; gastric emptying; incretin; insulin; type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：213 / 226
页数：13
相关论文
共 50 条
  • [1] The Once-Daily Human Glucagon-Like Peptide-1 (GLP-1) Analog Liraglutide Improves Postprandial Glucose Levels in Type 2 Diabetes Patients
    Flint, Anne
    Kapitza, Christoph
    Hindsberger, Charlotte
    Zdravkovic, Milan
    ADVANCES IN THERAPY, 2011, 28 (03) : 213 - 226
  • [2] The once-daily human glucagon-like peptide-1 analog, liraglutide, improves ß-cell function in Japanese patients with type 2 diabetes
    Seino, Yutaka
    Rasmussen, Mads Frederik
    Clauson, Per
    Kaku, Kohei
    JOURNAL OF DIABETES INVESTIGATION, 2012, 3 (04) : 388 - 395
  • [3] Liraglutide: A once-daily human glucagon-like peptide-1 analogue for type 2 diabetes mellitus
    Joffe, David
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (16) : 1326 - 1336
  • [4] Liraglutide: A once-daily human glucagon-like peptide-1 analogue
    Aimaretti, G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2009, 32 (08) : 701 - 703
  • [5] Liraglutide: A once-daily human glucagon-like peptide-1 analogue
    G. Aimaretti
    Journal of Endocrinological Investigation, 2009, 32 : 701 - 703
  • [6] Clinical Studies of Liraglutide, a Novel, Once-Daily Human Glucagon-Like Peptide-1 Analog for Improved Management of Type 2 Diabetes Mellitus
    Drab, Scott R.
    PHARMACOTHERAPY, 2009, 29 (12): : 43S - 54S
  • [7] The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis
    Li, Ya-Kun
    Ma, Dong-Xia
    Wang, Zhi-Min
    Hu, Xiao-Fan
    Li, Shang-Lin
    Tian, Hong-Zhe
    Wang, Meng-Jun
    Shu, Yan-Wen
    Yang, Jun
    PHARMACOLOGICAL RESEARCH, 2018, 131 : 102 - 111
  • [8] Liraglutide, a once-daily human GLP-1 analog, significantly improves β-cell function in subjects with type 2 diabetes
    Matthews, David
    Marre, Michel
    Le-Thl, T. U. Duyen
    Zdravkovic, Milan
    Simo, Rafael
    DIABETES, 2008, 57 : A150 - A151
  • [9] The effect of the once-daily human glucagon-like peptide 1 analog liraglutide on the pharmacokinetics of acetaminophen
    Christoph Kapitza
    Milan Zdravkovic
    Charlotte Hindsberger
    Anne Flint
    Advances in Therapy, 2011, 28 : 650 - 660
  • [10] Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes
    Courreges, J. -P.
    Vilsboll, T.
    Zdravkovic, M.
    Le-Thi, T.
    Krarup, T.
    Schmitz, O.
    Verhoeven, R.
    Buganova, I.
    Madsbad, S.
    DIABETIC MEDICINE, 2008, 25 (09) : 1129 - 1131
12345